Carna Biosciences, CrystalGenomics And Rigel Pharmaceuticals, Inc. (RIGL) Sign Service Agreement For X-Ray Crystal Structure Analysis 
10/19/2005 5:09:20 PM

Tokyo (JCNN) - Carna Biosciences of Kobe and Korean pharmaceutical company CrystalGenmomics jointly announced on June 20 that they have signed a service agreement with US pharmaceutical company Rigel Pharmaceuticals. Under the terms of the agreement, Carna Biosciences and CrystalGenomis will jointly provide X-ray crystal structure analysis service to Rigel Pharmaceuticals.